Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 7, 2023
Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamide
Thibaud Valentin, Marie Lambert, Léonor Chaltiel, et al.
Virchows Archiv : an International Journal of Pathology
|
January 31, 2025
EWSR1::CREM rearranged intra-abdominal malignant epithelioid neoplasm: two new cases of an emerging entity with clinicopathological characteristics and histological pitfalls
Mariam Rusidzé, François Poumeaud, Béatrice Akiki, et al.
BMC Cancer
|
August 2, 2020
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial
Thomas Filleron, Sophie Le Guellec, Christine Chevreau, et al.
Histopathology
|
August 24, 2018
Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
Margot Gaspard, Laurence Lamant, Emilie Tournier, et al.
Signal Transduction and Targeted Therapy
|
June 27, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab
Maud Toulmonde, Jean-Philippe Guégan, Mariella Spalato-Ceruso, et al.
Journal of Geriatric Oncology
|
March 15, 2021
VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients
Loïc Mourey, Félicien Le Louedec, Alain Ravaud, et al.
Cancer
|
September 5, 2025
Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study
Mina Fazel, Romain Varnier, Hélène Vanacker, et al.
Radiology and Oncology
|
December 1, 2023
Management of tumor volume changes during preoperative radiotherapy for extremity soft tissue sarcoma: a new strategy of adaptive radiotherapy
Marion Geneau De Lamarliere, Amélie Lusque, Justine Attal Khalifa, et al.
Bulletin Du Cancer
|
April 11, 2025
[Recurrent or refractory Osteosarcoma and Ewing sarcoma-French guidelines from the FSG/NETSARC and GroupOs groups]
Mehdi Brahmi, Maud Toulmonde, Sarah Winter, et al.
Investigational New Drugs
|
November 10, 2018
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors
Elena Elez, Carlos Gomez-Roca, Arturo Soto Matos-Pita, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 7, 2023
Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamide
Thibaud Valentin, Marie Lambert, Léonor Chaltiel, et al.
Virchows Archiv : an International Journal of Pathology
|
January 31, 2025
EWSR1::CREM rearranged intra-abdominal malignant epithelioid neoplasm: two new cases of an emerging entity with clinicopathological characteristics and histological pitfalls
Mariam Rusidzé, François Poumeaud, Béatrice Akiki, et al.
BMC Cancer
|
August 2, 2020
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial
Thomas Filleron, Sophie Le Guellec, Christine Chevreau, et al.
Histopathology
|
August 24, 2018
Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
Margot Gaspard, Laurence Lamant, Emilie Tournier, et al.
Signal Transduction and Targeted Therapy
|
June 27, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab
Maud Toulmonde, Jean-Philippe Guégan, Mariella Spalato-Ceruso, et al.
Journal of Geriatric Oncology
|
March 15, 2021
VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients
Loïc Mourey, Félicien Le Louedec, Alain Ravaud, et al.
Cancer
|
September 5, 2025
Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study
Mina Fazel, Romain Varnier, Hélène Vanacker, et al.
Radiology and Oncology
|
December 1, 2023
Management of tumor volume changes during preoperative radiotherapy for extremity soft tissue sarcoma: a new strategy of adaptive radiotherapy
Marion Geneau De Lamarliere, Amélie Lusque, Justine Attal Khalifa, et al.
Bulletin Du Cancer
|
April 11, 2025
[Recurrent or refractory Osteosarcoma and Ewing sarcoma-French guidelines from the FSG/NETSARC and GroupOs groups]
Mehdi Brahmi, Maud Toulmonde, Sarah Winter, et al.
Investigational New Drugs
|
November 10, 2018
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors
Elena Elez, Carlos Gomez-Roca, Arturo Soto Matos-Pita, et al.
Page
of 5